Macroview Investment Management’s DexCom DXCM Stock Holding History

Macroview Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-24	Closed	-$1.61K	–	219
2024 Q3	$1.61K	Hold	24	–	–	﹤0.01%	499
2024 Q2	$2.72K	Hold	24	–	–	﹤0.01%	458
2024 Q1	$3.33K	Sell	24 -62	-72%	-$7.79K	﹤0.01%	458
2023 Q4	$10.7K	Buy	86 +42	+95%	+$4.29K	0.01%	246
2023 Q3	$4.11K	Buy	44 +40	+1,000%	+$4.51K	0.01%	473
2023 Q2	$515	Hold	4	–	–	﹤0.01%	449
2023 Q1	$465	Hold	4	–	–	﹤0.01%	412
2022 Q4	$453	Hold	4	–	–	﹤0.01%	421
2022 Q3	$0	Sell	4 -4	-50%	-$339	﹤0.01%	437
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	392
2022 Q1	$1K	Hold	8	–	–	﹤0.01%	376
2021 Q4	$1K	Hold	8	–	–	﹤0.01%	345
2021 Q3	$1K	Hold	8	–	–	﹤0.01%	338
2021 Q2	$1K	Hold	8	–	–	﹤0.01%	363
2021 Q1	$1K	Hold	8	–	–	﹤0.01%	339
2020 Q4	$1K	Hold	8	–	–	﹤0.01%	314
2020 Q3	$1K	Buy	+8	New	+$836	﹤0.01%	288
2020 Q1	–	Sell	-68	Closed	-$4K	–	313
2019 Q4	$4K	Buy	+68	New	+$3.23K	0.01%	186
2019 Q2	–	Sell	-88	Closed	-$3K	–	317
2019 Q1	$3K	Sell	88 -8	-8%	-$281	0.01%	235
2018 Q4	$3K	Buy	+96	New	+$3.04K	0.01%	194
2018 Q3	–	Sell	-136	Closed	-$3K	–	331
2018 Q2	$3K	Buy	+136	New	+$2.88K	0.01%	181

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Macroview Investment Management's DXCM Position: Q4 2024 in Review

Macroview Investment Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 24 shares — an estimated $1.61K sold.

Macroview Investment Management first reported a position in DXCM in Q2 2018 and held it in 21 quarters. The position peaked at $10.7K in Q4 2023. 952 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

Macroview Investment Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
Macroview Investment Management sold 24 DexCom shares in Q4 2024, an estimated $1.61K.
Macroview Investment Management first reported a position in DexCom in Q2 2018 and held it in 21 quarters.
Macroview Investment Management's DexCom position peaked at $10.7K in Q4 2023.
952 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.